Horsham, PA - March 2, 2004 - NextGen Healthcare Information Systems Inc., a subsidiary of Quality Systems, Inc. (Nasdaq: QSII), today announced that the company�s NextGen� EPM (Enterprise Practice Management) and NextGen� EMR (Electronic Medical Records) applications were awarded top honors in the Administrative/Financial Systems and Ambulatory Care: Clinical/Patient Information Systems categories of the MS-HUG Industry Solution Awards for the 2nd consecutive year. The awards were presented during a ceremony conducted in connection with the Healthcare Information and Management Systems Society (HIMSS) conference in Orlando, Florida.
MS-HUG holds the annual Industry Solutions Awards for Healthcare (ISAH) to recognize individuals and organizations in the healthcare industry for their innovative development on, and use of, Microsoft technology to provide tangible business benefits and improved patient care. Vendor�s solutions were scored according to the following criteria: business benefit to the customer, business agility, ease of adoption, solutions architecture used in developing the solution, and technical challenges.
About MS-HUG
With headquarters in Ann Arbor, Mich., the independent, nonprofit Microsoft Healthcare Users Group is the leading healthcare industry forum for exchanging ideas, promoting learning and sharing solutions for information systems using Microsoft technologies. MS-HUG works to provide industry leadership, drive appropriate standards and develop associated requirements in support of healthcare solutions. The diverse membership of MS-HUG is united by a shared interest in implementing vendor- and user-developed software based on Microsoft technology to improve quality and efficiency in healthcare. More information can be found on MS-HUG�s Web site at www.mshug.org.
About NextGen Healthcare Information Systems, Inc.
NextGen Healthcare Information Systems, a wholly owned subsidiary of Quality Systems Inc., develops and provides computer-based practice management, medical records, and connectivity applications for medical group practices. Visit www.nextgen.com and www.qsii.com for additional information.
This news release may contain forward-looking statements within the meaning of the federal securities laws. Statements regarding future events, developments, the Company's future performance, as well as management's expectations, beliefs, intentions, plans, estimates or projections relating to the future (including, without limitation, statements concerning revenue and net income), are forward-looking statements within the meaning of these laws and involve a number of risks and uncertainties. Management believes that these forward-looking statements are reasonable and are based on reasonable assumptions and forecasts, however, undue reliance should not be placed on such statements that speak only as of the date hereof. Moreover, these forward-looking statements are subject to a number of risks and uncertainties, some of which are outlined below. As a result, actual results may vary materially from those anticipated by the forward-looking statements. Among the important factors that could cause actual results to differ materially from those indicated by such forward-looking statements are: volume and timing of systems sales and installations; length of sales cycles and installation process; the possibility that the products will not achieve market acceptance; seasonal patterns of sales and customer buying behavior; the development by competitors of new or superior technologies; the timing, cost and success or failure of new product and service introductions, development and product upgrade releases; undetected errors or bugs in software; product liability; changing economic, political or regulatory influences in the health-care industry; changes in product-pricing policies; availability of third-party products and components; competitive pressures including product offerings, pricing and promotional activities; the Company's ability or inability to attract and retain qualified personnel; possible regulation of the Company's software by the U.S. Food and Drug Administration; uncertainties concerning threatened, pending and new litigation against the Company including related professional services fees; uncertainties concerning the amount and timing of professional fees incurred by the Company generally; changes of accounting estimates and assumptions used to prepare the prior periods' financial statements; general economic conditions; and the risk factors detailed from time to time in Quality Systems' periodic reports and registration statements filed with the Securities and Exchange Commission. A significant portion of the Company's quarterly sales of software product licenses and computer hardware is concluded in the last month of the fiscal quarter, generally with a concentration of such revenues earned in the final ten business days of that month. Due to these and other factors, the Company's revenues and operating results are very difficult to forecast. A major portion of the Company's costs and expenses, such as personnel and facilities, are of a fixed nature and, accordingly, a shortfall or decline in quarterly and/or annual revenues typically results in lower profitability or losses. As a result, comparison of the Company's period-to-period financial performance is not necessarily meaningful and should not be relied upon as an indicator of future performance. The Company undertakes no obligation to publicly update any forward-looking statements, whether as a result of new information, future events or otherwise.
